1 Pravastatin Market Overview 1.1 Product Overview and Scope of Pravastatin 1.2 Pravastatin Segment by Type 1.2.1 Global Pravastatin Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 10mg Tablet 1.2.3 20mg Tablet 1.2.4 40mg Tablet 1.2.5 80mg Tablet 1.3 Pravastatin Segment by Application 1.3.1 Global Pravastatin Sales Comparison by Application: (2021-2027) 1.3.2 Adults 1.3.3 Children 1.4 Global Pravastatin Market Size Estimates and Forecasts 1.4.1 Global Pravastatin Revenue 2016-2027 1.4.2 Global Pravastatin Sales 2016-2027 1.4.3 Pravastatin Market Size by Region: 2016 Versus 2021 Versus 2027 2 Pravastatin Market Competition by Manufacturers 2.1 Global Pravastatin Sales Market Share by Manufacturers (2016-2021) 2.2 Global Pravastatin Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Pravastatin Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Pravastatin Manufacturing Sites, Area Served, Product Type 2.5 Pravastatin Market Competitive Situation and Trends 2.5.1 Pravastatin Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Pravastatin Players Market Share by Revenue 2.5.3 Global Pravastatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Pravastatin Retrospective Market Scenario by Region 3.1 Global Pravastatin Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Pravastatin Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Pravastatin Market Facts & Figures by Country 3.3.1 North America Pravastatin Sales by Country 3.3.2 North America Pravastatin Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Pravastatin Market Facts & Figures by Country 3.4.1 Europe Pravastatin Sales by Country 3.4.2 Europe Pravastatin Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Pravastatin Market Facts & Figures by Region 3.5.1 Asia Pacific Pravastatin Sales by Region 3.5.2 Asia Pacific Pravastatin Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Pravastatin Market Facts & Figures by Country 3.6.1 Latin America Pravastatin Sales by Country 3.6.2 Latin America Pravastatin Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Pravastatin Market Facts & Figures by Country 3.7.1 Middle East and Africa Pravastatin Sales by Country 3.7.2 Middle East and Africa Pravastatin Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Pravastatin Historic Market Analysis by Type 4.1 Global Pravastatin Sales Market Share by Type (2016-2021) 4.2 Global Pravastatin Revenue Market Share by Type (2016-2021) 4.3 Global Pravastatin Price by Type (2016-2021) 5 Global Pravastatin Historic Market Analysis by Application 5.1 Global Pravastatin Sales Market Share by Application (2016-2021) 5.2 Global Pravastatin Revenue Market Share by Application (2016-2021) 5.3 Global Pravastatin Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Bristol-Myers Squibb 6.1.1 Bristol-Myers Squibb Corporation Information 6.1.2 Bristol-Myers Squibb Description and Business Overview 6.1.3 Bristol-Myers Squibb Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Bristol-Myers Squibb Pravastatin Product Portfolio 6.1.5 Bristol-Myers Squibb Recent Developments/Updates 6.2 TEVA 6.2.1 TEVA Corporation Information 6.2.2 TEVA Description and Business Overview 6.2.3 TEVA Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.2.4 TEVA Pravastatin Product Portfolio 6.2.5 TEVA Recent Developments/Updates 6.3 SANDOZ 6.3.1 SANDOZ Corporation Information 6.3.2 SANDOZ Description and Business Overview 6.3.3 SANDOZ Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.3.4 SANDOZ Pravastatin Product Portfolio 6.3.5 SANDOZ Recent Developments/Updates 6.4 APOTEX 6.4.1 APOTEX Corporation Information 6.4.2 APOTEX Description and Business Overview 6.4.3 APOTEX Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.4.4 APOTEX Pravastatin Product Portfolio 6.4.5 APOTEX Recent Developments/Updates 6.5 Dr. Reddy's Laboratories 6.5.1 Dr. Reddy's Laboratories Corporation Information 6.5.2 Dr. Reddy's Laboratories Description and Business Overview 6.5.3 Dr. Reddy's Laboratories Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Dr. Reddy's Laboratories Pravastatin Product Portfolio 6.5.5 Dr. Reddy's Laboratories Recent Developments/Updates 6.6 Zydus Pharmaceuticals 6.6.1 Zydus Pharmaceuticals Corporation Information 6.6.2 Zydus Pharmaceuticals Description and Business Overview 6.6.3 Zydus Pharmaceuticals Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Zydus Pharmaceuticals Pravastatin Product Portfolio 6.6.5 Zydus Pharmaceuticals Recent Developments/Updates 6.7 Cipla Inc. 6.6.1 Cipla Inc. Corporation Information 6.6.2 Cipla Inc. Description and Business Overview 6.6.3 Cipla Inc. Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Cipla Inc. Pravastatin Product Portfolio 6.7.5 Cipla Inc. Recent Developments/Updates 6.8 Lupin Pharmaceuticals 6.8.1 Lupin Pharmaceuticals Corporation Information 6.8.2 Lupin Pharmaceuticals Description and Business Overview 6.8.3 Lupin Pharmaceuticals Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Lupin Pharmaceuticals Pravastatin Product Portfolio 6.8.5 Lupin Pharmaceuticals Recent Developments/Updates 6.9 Glenmark 6.9.1 Glenmark Corporation Information 6.9.2 Glenmark Description and Business Overview 6.9.3 Glenmark Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Glenmark Pravastatin Product Portfolio 6.9.5 Glenmark Recent Developments/Updates 6.10 Mylan 6.10.1 Mylan Corporation Information 6.10.2 Mylan Description and Business Overview 6.10.3 Mylan Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Mylan Pravastatin Product Portfolio 6.10.5 Mylan Recent Developments/Updates 6.11 Aurobindo Pharma 6.11.1 Aurobindo Pharma Corporation Information 6.11.2 Aurobindo Pharma Pravastatin Description and Business Overview 6.11.3 Aurobindo Pharma Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Aurobindo Pharma Pravastatin Product Portfolio 6.11.5 Aurobindo Pharma Recent Developments/Updates 6.12 Accord Healthcare 6.12.1 Accord Healthcare Corporation Information 6.12.2 Accord Healthcare Pravastatin Description and Business Overview 6.12.3 Accord Healthcare Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Accord Healthcare Pravastatin Product Portfolio 6.12.5 Accord Healthcare Recent Developments/Updates 6.13 Upsher-Smith Laboratories 6.13.1 Upsher-Smith Laboratories Corporation Information 6.13.2 Upsher-Smith Laboratories Pravastatin Description and Business Overview 6.13.3 Upsher-Smith Laboratories Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Upsher-Smith Laboratories Pravastatin Product Portfolio 6.13.5 Upsher-Smith Laboratories Recent Developments/Updates 6.14 Hisun 6.14.1 Hisun Corporation Information 6.14.2 Hisun Pravastatin Description and Business Overview 6.14.3 Hisun Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.14.4 Hisun Pravastatin Product Portfolio 6.14.5 Hisun Recent Developments/Updates 6.15 Jiangxi Boyaseehot Pharmaceutical 6.15.1 Jiangxi Boyaseehot Pharmaceutical Corporation Information 6.15.2 Jiangxi Boyaseehot Pharmaceutical Pravastatin Description and Business Overview 6.15.3 Jiangxi Boyaseehot Pharmaceutical Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.15.4 Jiangxi Boyaseehot Pharmaceutical Pravastatin Product Portfolio 6.15.5 Jiangxi Boyaseehot Pharmaceutical Recent Developments/Updates 6.16 Shanghai Shyndec Pharmaceutical 6.16.1 Shanghai Shyndec Pharmaceutical Corporation Information 6.16.2 Shanghai Shyndec Pharmaceutical Pravastatin Description and Business Overview 6.16.3 Shanghai Shyndec Pharmaceutical Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.16.4 Shanghai Shyndec Pharmaceutical Pravastatin Product Portfolio 6.16.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates 6.17 Daiichi Sankyo 6.17.1 Daiichi Sankyo Corporation Information 6.17.2 Daiichi Sankyo Pravastatin Description and Business Overview 6.17.3 Daiichi Sankyo Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.17.4 Daiichi Sankyo Pravastatin Product Portfolio 6.17.5 Daiichi Sankyo Recent Developments/Updates 6.18 North China Pharmaceutical Group 6.18.1 North China Pharmaceutical Group Corporation Information 6.18.2 North China Pharmaceutical Group Pravastatin Description and Business Overview 6.18.3 North China Pharmaceutical Group Pravastatin Sales, Revenue and Gross Margin (2016-2021) 6.18.4 North China Pharmaceutical Group Pravastatin Product Portfolio 6.18.5 North China Pharmaceutical Group Recent Developments/Updates 7 Pravastatin Manufacturing Cost Analysis 7.1 Pravastatin Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Pravastatin 7.4 Pravastatin Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Pravastatin Distributors List 8.3 Pravastatin Customers 9 Pravastatin Market Dynamics 9.1 Pravastatin Industry Trends 9.2 Pravastatin Growth Drivers 9.3 Pravastatin Market Challenges 9.4 Pravastatin Market Restraints 10 Global Market Forecast 10.1 Pravastatin Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Pravastatin by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Pravastatin by Type (2022-2027) 10.2 Pravastatin Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Pravastatin by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Pravastatin by Application (2022-2027) 10.3 Pravastatin Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Pravastatin by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Pravastatin by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Pravastatin Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Pravastatin Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Pravastatin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Pravastatin Covered in This Study Table 5. Global Pravastatin Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Pravastatin Sales Market Share by Manufacturers (2016-2021) Table 7. Global Pravastatin Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Pravastatin Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Pravastatin Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Pravastatin Manufacturing Sites and Area Served Table 11. Manufacturers Pravastatin Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Pravastatin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pravastatin as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Pravastatin Sales by Region (2016-2021) & (K Units) Table 16. Global Pravastatin Sales Market Share by Region (2016-2021) Table 17. Global Pravastatin Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Pravastatin Sales by Country (2016-2021) & (K Units) Table 19. North America Pravastatin Sales Market Share by Country (2016-2021) Table 20. North America Pravastatin Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Pravastatin Revenue Market Share by Country (2016-2021) Table 22. Europe Pravastatin Sales by Country (2016-2021) & (K Units) Table 23. Europe Pravastatin Sales Market Share by Country (2016-2021) Table 24. Europe Pravastatin Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Pravastatin Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Pravastatin Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Pravastatin Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Pravastatin Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Pravastatin Revenue Market Share by Region (2016-2021) Table 30. Latin America Pravastatin Sales by Country (2016-2021) & (K Units) Table 31. Latin America Pravastatin Sales Market Share by Country (2016-2021) Table 32. Latin America Pravastatin Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Pravastatin Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Pravastatin Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Pravastatin Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Pravastatin Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Pravastatin Revenue Market Share by Country (2016-2021) Table 38. Global Pravastatin Sales (K Units) by Type (2016-2021) Table 39. Global Pravastatin Sales Market Share by Type (2016-2021) Table 40. Global Pravastatin Revenue (Million US$) by Type (2016-2021) Table 41. Global Pravastatin Revenue Share by Type (2016-2021) Table 42. Global Pravastatin Price (USD/Unit) by Type (2016-2021) Table 43. Global Pravastatin Sales (K Units) by Application (2016-2021) Table 44. Global Pravastatin Sales Market Share by Application (2016-2021) Table 45. Global Pravastatin Revenue (Million US$) by Application (2016-2021) Table 46. Global Pravastatin Revenue Share by Application (2016-2021) Table 47. Global Pravastatin Price (USD/Unit) by Application (2016-2021) Table 48. Bristol-Myers Squibb Corporation Information Table 49. Bristol-Myers Squibb Description and Business Overview Table 50. Bristol-Myers Squibb Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Bristol-Myers Squibb Pravastatin Product Table 52. Bristol-Myers Squibb Recent Developments/Updates Table 53. TEVA Corporation Information Table 54. TEVA Description and Business Overview Table 55. TEVA Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. TEVA Pravastatin Product Table 57. TEVA Recent Developments/Updates Table 58. SANDOZ Corporation Information Table 59. SANDOZ Description and Business Overview Table 60. SANDOZ Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. SANDOZ Pravastatin Product Table 62. SANDOZ Recent Developments/Updates Table 63. APOTEX Corporation Information Table 64. APOTEX Description and Business Overview Table 65. APOTEX Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. APOTEX Pravastatin Product Table 67. APOTEX Recent Developments/Updates Table 68. Dr. Reddy's Laboratories Corporation Information Table 69. Dr. Reddy's Laboratories Description and Business Overview Table 70. Dr. Reddy's Laboratories Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Dr. Reddy's Laboratories Pravastatin Product Table 72. Dr. Reddy's Laboratories Recent Developments/Updates Table 73. Zydus Pharmaceuticals Corporation Information Table 74. Zydus Pharmaceuticals Description and Business Overview Table 75. Zydus Pharmaceuticals Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Zydus Pharmaceuticals Pravastatin Product Table 77. Zydus Pharmaceuticals Recent Developments/Updates Table 78. Cipla Inc. Corporation Information Table 79. Cipla Inc. Description and Business Overview Table 80. Cipla Inc. Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Cipla Inc. Pravastatin Product Table 82. Cipla Inc. Recent Developments/Updates Table 83. Lupin Pharmaceuticals Corporation Information Table 84. Lupin Pharmaceuticals Description and Business Overview Table 85. Lupin Pharmaceuticals Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Lupin Pharmaceuticals Pravastatin Product Table 87. Lupin Pharmaceuticals Recent Developments/Updates Table 88. Glenmark Corporation Information Table 89. Glenmark Description and Business Overview Table 90. Glenmark Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Glenmark Pravastatin Product Table 92. Glenmark Recent Developments/Updates Table 93. Mylan Corporation Information Table 94. Mylan Description and Business Overview Table 95. Mylan Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Mylan Pravastatin Product Table 97. Mylan Recent Developments/Updates Table 98. Aurobindo Pharma Corporation Information Table 99. Aurobindo Pharma Description and Business Overview Table 100. Aurobindo Pharma Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. Aurobindo Pharma Pravastatin Product Table 102. Aurobindo Pharma Recent Developments/Updates Table 103. Accord Healthcare Corporation Information Table 104. Accord Healthcare Description and Business Overview Table 105. Accord Healthcare Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. Accord Healthcare Pravastatin Product Table 107. Accord Healthcare Recent Developments/Updates Table 108. Upsher-Smith Laboratories Corporation Information Table 109. Upsher-Smith Laboratories Description and Business Overview Table 110. Upsher-Smith Laboratories Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 111. Upsher-Smith Laboratories Pravastatin Product Table 112. Upsher-Smith Laboratories Recent Developments/Updates Table 113. Hisun Corporation Information Table 114. Hisun Description and Business Overview Table 115. Hisun Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 116. Hisun Pravastatin Product Table 117. Hisun Recent Developments/Updates Table 118. Jiangxi Boyaseehot Pharmaceutical Corporation Information Table 119. Jiangxi Boyaseehot Pharmaceutical Description and Business Overview Table 120. Jiangxi Boyaseehot Pharmaceutical Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 121. Jiangxi Boyaseehot Pharmaceutical Pravastatin Product Table 122. Jiangxi Boyaseehot Pharmaceutical Recent Developments/Updates Table 123. Shanghai Shyndec Pharmaceutical Corporation Information Table 124. Shanghai Shyndec Pharmaceutical Description and Business Overview Table 125. Shanghai Shyndec Pharmaceutical Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 126. Shanghai Shyndec Pharmaceutical Pravastatin Product Table 127. Shanghai Shyndec Pharmaceutical Recent Developments/Updates Table 128. Daiichi Sankyo Corporation Information Table 129. Daiichi Sankyo Description and Business Overview Table 130. Daiichi Sankyo Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 131. Daiichi Sankyo Pravastatin Product Table 132. Daiichi Sankyo Recent Developments/Updates Table 133. North China Pharmaceutical Group Corporation Information Table 134. North China Pharmaceutical Group Description and Business Overview Table 135. North China Pharmaceutical Group Pravastatin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 136. North China Pharmaceutical Group Pravastatin Product Table 137. North China Pharmaceutical Group Recent Developments/Updates Table 138. Production Base and Market Concentration Rate of Raw Material Table 139. Key Suppliers of Raw Materials Table 140. Pravastatin Distributors List Table 141. Pravastatin Customers List Table 142. Pravastatin Market Trends Table 143. Pravastatin Growth Drivers Table 144. Pravastatin Market Challenges Table 145. Pravastatin Market Restraints Table 146. Global Pravastatin Sales Forecast by Type (2022-2027) & (K Units) Table 147. Global Pravastatin Sales Market Share Forecast by Type (2022-2027) Table 148. Global Pravastatin Revenue Forecast by Type (2022-2027) & (US$ Million) Table 149. Global Pravastatin Revenue Market Share Forecast by Type (2022-2027) Table 150. Global Pravastatin Sales Forecast by Application (2022-2027) & (K Units) Table 151. Global Pravastatin Sales Market Share Forecast by Application (2022-2027) Table 152. Global Pravastatin Revenue Forecast by Application (2022-2027) & (US$ Million) Table 153. Global Pravastatin Revenue Market Share Forecast by Application (2022-2027) Table 154. Global Pravastatin Sales Forecast by Region (2022-2027) & (K Units) Table 155. Global Pravastatin Sales Market Share Forecast by Region (2022-2027) Table 156. Global Pravastatin Revenue Forecast by Region (2022-2027) & (US$ Million) Table 157. Global Pravastatin Revenue Market Share Forecast by Region (2022-2027) Table 158. Research Programs/Design for This Report Table 159. Key Data Information from Secondary Sources Table 160. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Pravastatin Figure 2. Global Pravastatin Market Share by Type in 2020 & 2027 Figure 3. 10mg Tablet Product Picture Figure 4. 20mg Tablet Product Picture Figure 5. 40mg Tablet Product Picture Figure 6. 80mg Tablet Product Picture Figure 7. Global Pravastatin Market Share by Application in 2020 & 2027 Figure 8. Adults Figure 9. Children Figure 10. Global Pravastatin Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Pravastatin Market Size 2016-2027 (US$ Million) Figure 12. Global Pravastatin Sales 2016-2027 (K Units) Figure 13. Global Pravastatin Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 14. Pravastatin Sales Share by Manufacturers in 2020 Figure 15. Global Pravastatin Revenue Share by Manufacturers in 2020 Figure 16. The Global 5 and 10 Largest Pravastatin Players: Market Share by Revenue in 2020 Figure 17. Pravastatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 18. Global Pravastatin Sales Market Share by Region (2016-2021) Figure 19. Global Pravastatin Sales Market Share by Region in 2020 Figure 20. Global Pravastatin Revenue Market Share by Region (2016-2021) Figure 21. Global Pravastatin Revenue Market Share by Region in 2020 Figure 22. U.S. Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Canada Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. U.K. Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Taiwan Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Indonesia Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Thailand Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Malaysia Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Philippines Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Vietnam Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Mexico Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Brazil Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Argentina Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Turkey Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Saudi Arabia Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. U.A.E Pravastatin Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Sales Market Share of Pravastatin by Type (2016-2021) Figure 47. Sales Market Share of Pravastatin by Application (2016-2021) Figure 48. Sales Market Share of Pravastatin by Application in 2020 Figure 49. Revenue Share of Pravastatin by Application (2016-2021) Figure 50. Revenue Share of Pravastatin by Application in 2020 Figure 51. Manufacturing Cost Structure of Pravastatin Figure 52. Manufacturing Process Analysis of Pravastatin Figure 53. Pravastatin Industrial Chain Analysis Figure 54. Channels of Distribution Figure 55. Distributors Profiles Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Bristol-Myers Squibb TEVA SANDOZ APOTEX Dr. Reddy's Laboratories Zydus Pharmaceuticals Cipla Inc. Lupin Pharmaceuticals Glenmark Mylan Aurobindo Pharma Accord Healthcare Upsher-Smith Laboratories Hisun Jiangxi Boyaseehot Pharmaceutical Shanghai Shyndec Pharmaceutical Daiichi Sankyo North China Pharmaceutical Group